WAUI
JNJ icon

WELLINGTON-ALTUS USA INC.’s Johnson & Johnson JNJ Stock Holding History

WELLINGTON-ALTUS USA INC.’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-104
Closed -$21.5K – 727
2025
Q4 		$21.5K Buy
+104
New +$20.6K 0.02% 470

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WELLINGTON-ALTUS USA INC.'s JNJ Position: Q1 2026 in Review

WELLINGTON-ALTUS USA INC. sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 104 shares — an estimated $21.5K sold.

WELLINGTON-ALTUS USA INC. first reported a position in JNJ in Q4 2025 and held it in 1 quarter. The position peaked at $21.5K in Q4 2025. 4,657 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • WELLINGTON-ALTUS USA INC. reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • WELLINGTON-ALTUS USA INC. sold 104 Johnson & Johnson shares in Q1 2026, an estimated $21.5K.
  • WELLINGTON-ALTUS USA INC. first reported a position in Johnson & Johnson in Q4 2025 and held it in 1 quarter.
  • WELLINGTON-ALTUS USA INC.'s Johnson & Johnson position peaked at $21.5K in Q4 2025.
  • 4,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on WELLINGTON-ALTUS USA INC.'s 13F filing for Q1 2026, filed 17 Sep 2026.